Association of Skeletal Muscle and Adipose Tissue Distribution with Histologic Severity of Non-Alcoholic Fatty Liver

Association of Skeletal Muscle and Adipose Tissue Distribution with Histologic Severity of Non-Alcoholic Fatty Liver

Adipose tissue and skeletal muscle is associated with non-alcoholic fatty liver disease (NAFLD). This study evaluates the association between body composition and histologic severity in patients with NAFLD. Using the cross-sectional CT images at the level of L3 vertebra and the histologic findings o...

Full description

Bibliographic Details
Main Authors:	Min-Kyu Kang, Jung-Hun Baek, Young-Oh Kweon, Won-Young Tak, Se-Young Jang, Yu-Rim Lee, Keun Hur, Gyeonghwa Kim, Hye-Won Lee, Man-Hoon Han, Joon-Hyuk Choi, Soo-Young Park, Jung-Gil Park
Format:	Article
Language:	English
Published:	MDPI AG 2021-06-01
Series:	Diagnostics
Subjects:	non-alcoholic fatty liver disease non-alcoholic steatohepatitis sarcopenia adipose tissue skeletal muscle body composition
Online Access:	https://www.mdpi.com/2075-4418/11/6/1061

Similar Items

Plasma Long Noncoding RNA <i>LeXis</i> is a Potential Diagnostic Marker for Non-Alcoholic Steatohepatitis
by: Jung Gil Park, et al.
Published: (2020-10-01)

A scoring system for the diagnosis of non-alcoholic steatohepatitis from liver biopsy
by: Kyoungbun Lee, et al.
Published: (2020-05-01)

Comparison of clinical, biochemical and histological features of alcoholic steatohepatitis and non-alcoholic steatohepatitis in Asian Indian patients
by: Singh Deepak, et al.
Published: (2010-07-01)

Binary Bacillus subtilis protects the intestinal mucosa barrier and alleviates nonalcoholic steatohepatitis
by: Donglin Liu, et al.
Published: (2024-06-01)

Association of Myosteatosis with Nonalcoholic Fatty Liver Disease, Severity, and Liver Fibrosis Using Visual Muscular Quality Map in Computed Tomography
by: Hwi Seung Kim, et al.
Published: (2023-01-01)

Structure of anaemic conditions comorbid to alcoholic and non-alcoholic steatohepatitis
by: Oksana Khukhlina, et al.
Published: (2021-05-01)

Relationship between Muscle Mass and Non-Alcoholic Fatty Liver Disease
by: Jun-Hyuk Lee, et al.
Published: (2021-02-01)

Impact of Skeletal Muscle Mass on Metabolic Health
by: Gyuri Kim, et al.
Published: (2020-03-01)

Age-Related Decrease in Skeletal Muscle Mass Is an Independent Risk Factor for Incident Nonalcoholic Fatty Liver Disease: A 10-Year Retrospective Cohort Study
by: Min Jung Lee, et al.
Published: (2019-01-01)

A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ALS-L1023 in Non-Alcoholic Fatty Liver Disease
by: Gi-Ae Kim, et al.
Published: (2023-04-01)

Differences among Three Skeletal Muscle Mass Indices in Predicting Non-Alcoholic Fatty Liver Disease: Korean Nationwide Population-Based Study
by: A-Ra Cho, et al.
Published: (2021-07-01)

Comparison of FibroScan-Aspartate Aminotransferase (FAST) Score and Other Non-invasive Surrogates in Predicting High-Risk Non-alcoholic Steatohepatitis Criteria
by: Jae Seung Lee, et al.
Published: (2022-04-01)

Triglyceride Glucose Index is Associated with Ultrasonographic Fatty Liver Indicator in Children and Adolescents with Non-alcoholic Fatty Liver Disease
by: Bitgyeol Kim, et al.
Published: (2024-09-01)

Association Between Low Muscle Mass and Non-alcoholic Fatty Liver Disease Diagnosed Using Ultrasonography, Magnetic Resonance Imaging Derived Proton Density Fat Fraction, and Comprehensive NAFLD Score in Korea
by: Hun Ju Lee, et al.
Published: (2021-11-01)

Correspondence on Letter regarding “Non-alcoholic fatty liver disease: Definition and subtypes”
by: Seul Ki Han, et al.
Published: (2023-07-01)

Non-alcoholic fatty liver disease: Definition and subtypes
by: Seul Ki Han, et al.
Published: (2023-02-01)

Dietary Oleate Has Beneficial Effects on Every Step of Non-Alcoholic Fatty Liver Disease Progression in a Methionine- and Choline-Deficient Diet-Fed Animal Model
by: Ji Young Lee, et al.
Published: (2011-10-01)

Presence and Implications of Sarcopenia in Non-alcoholic Steatohepatitis
by: Gregory Habig, et al.
Published: (2021-04-01)

Fermented field water-dropwort (Oenanthe javanica) alleviates diet-induced non-alcoholic steatohepatitis
by: Dong Hun Lee, et al.
Published: (2022-12-01)

Application of ursodeoxycholic acid at non-alcoholic and alcohol-induced steatohepatitis
by: Ye. A. Fedos’ina, et al.
Published: (2010-06-01)

6-Shogaol Ameliorates Liver Inflammation and Fibrosis in Mice on a Methionine- and Choline-Deficient Diet by Inhibiting Oxidative Stress, Cell Death, and Endoplasmic Reticulum Stress
by: Ah Young Yang, et al.
Published: (2024-01-01)

Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study
by: Hyeok-Hee Lee, et al.
Published: (2020-06-01)

Liver Injury and Cell Survival in Non-Alcoholic Steatohepatitis Regulated by Sex-Based Difference through B Cell Lymphoma 6
by: Akihide Kamiya, et al.
Published: (2022-11-01)

IMAGING DIAGNOSIS OF NONALCOHOLIC STEATOHEPATITIS
by: Anca Smaranda Farmazon, et al.
Published: (2018-09-01)

ALS-L1023 from <i>Melissa officinalis</i> Alleviates Liver Fibrosis in a Non-Alcoholic Fatty Liver Disease Model
by: Eun Jeoung Lee, et al.
Published: (2022-12-01)

Epidemiology of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in Japan: A focused literature review
by: Yuichiro Eguchi, et al.
Published: (2020-10-01)

Effects of Metformin on Hepatic Steatosis in Adults with Nonalcoholic Fatty Liver Disease and Diabetes: Insights from the Cellular to Patient Levels
by: Kanokwan Pinyopornpanish, et al.
Published: (2021-11-01)

NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications
Published: (2012-04-01)

Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
by: Daryl Ramai, et al.
Published: (2021-12-01)

Use of a controlled attenuation parameter for the diagnosis of non-alcoholic fatty liver disease
by: Alexey A. Goncharov, et al.
Published: (2023-10-01)

Assessing whether serum ceruloplasmin promotes non-alcoholic steatohepatitis via regulating iron metabolism
by: Xia Ziqiang, et al.
Published: (2023-01-01)

Non-alcoholic fatty liver disease and steatohepatitis: State of the art on effective therapeutics based on the gold standard method for diagnosis
by: Maryam Mahjoubin-Tehran, et al.
Published: (2021-08-01)

NON-ALCOHOLIC STEATOHEPATITIS IN CHILDREN − A PRACTICAL APPROACH WITH CASE REPORT
by: Ana Šinkovec, et al.
Published: (2021-10-01)

Longitudinal characterization of diet-induced genetic murine models of non-alcoholic steatohepatitis with metabolic, histological, and transcriptomic hallmarks of human patients
by: Naomichi Abe, et al.
Published: (2019-05-01)

Role of silymarin in the management of deranged liver function in non-alcoholic steatohepatitis: a case report
by: Yeong Yeh Lee, et al.
Published: (2023-01-01)

NASH and cryptogenic cirrhosis: A histological analysis†† Financial Support/Grants: This research supported in part by the Intramural Research Program of the NIH, National Cancer Institute.
by: Stephen H. Caldwell, et al.
Published: (2009-10-01)

Can Walnut Serve as a Magic Bullet for the Management of Non-Alcoholic Fatty Liver Disease?
by: Mi-Young Kim, et al.
Published: (2020-12-01)

Sarcopenia Is Significantly Associated with Presence and Severity of Nonalcoholic Fatty Liver Disease
by: Goh Eun Chung, et al.
Published: (2019-06-01)

Appendicular Skeletal Muscle Mass to Visceral Fat Area Ratio Predicts Hepatic Morbidities
by: Eugene Han, et al.
Published: (2024-05-01)

Non-invasive diagnosis of non-alcoholic fatty liver disease: Current status and future perspective
by: Jia-Lan Wang, et al.
Published: (2024-03-01)